|
1
|
Shiozawa Y, Nie B, Pienta KJ, Morgan TM
and Taichman RS: Cancer stem cells and their role in metastasis.
Pharmacol Ther. 138:285–293. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cheng X and O’Neill HC: Oncogenesis and
cancer stem cells: current opinions and future directions. J Cell
Mol Med. 13:4377–4384. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yamashita T and Wang XW: Cancer stem cells
in the development of liver cancer. J Clin Invest. 123:1911–1918.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Padhya KT, Marrero JA and Singal AG:
Recent advances in the treatment of hepatocellular carcinoma. Curr
Opin Gastroenterol. 29:285–292. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wilson GS, Hu Z, Duan W, et al: Efficacy
of using cancer stem cell markers in isolating and characterizing
liver cancer stem cells. Stem Cells Dev. 22:2655–2664. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee H, Kim JB, Park SY, Kim SS and Kim H:
Combination effect of paclitaxel and hyaluronic acid on cancer
stem-like side population cells. J Biomed Nanotechnol. 9:299–302.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zheng L, Liang P, Li J, et al:
ShRNA-targeted COMMD7 suppresses hepatocellular carcinoma growth.
PLoS One. 7:e454122012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zheng L, Huang X, Liang P, et al: BC047440
overexpression is a risk factor for tumor invasion and poor
prognosis in hepatocellular carcinoma. Hepatogastroenterology.
57:919–925. 2010.PubMed/NCBI
|
|
9
|
Zheng L, Liang P, Zhou J, Huang X, Wen Y,
Wang Z and Li J: BC047440 antisense eukaryotic expression vectors
inhibited HepG2 cell proliferation and suppressed xenograft
tumorigenicity. Braz J Med Biol Res. 45:97–103. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu WH, Li R and Dou KF: Convenient and
efficient enrichment of the CD133+ liver cells from rat
fetal liver cells as a source of liver stem/progenitor cells. Stem
Cell Rev. 7:94–102. 2011.PubMed/NCBI
|
|
11
|
Liu WH, Wang X, You N, et al: Efficient
enrichment of hepatic cancer stem-like cells from a primary rat HCC
model via a density gradient centrifugation-centered method. PLoS
One. 7:e357202012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li CH, Wang YJ, Dong W, et al: Hepatic
oval cell lines generate hepatocellular carcinoma following
transfection with HBx gene and treatment with aflatoxin B1 in vivo.
Cancer Lett. 311:1–10. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chiba T, Kita K, Zheng YW, et al: Side
population purified from hepatocellular carcinoma cells harbors
cancer stem cell-like properties. Hepatology. 44:240–245. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhu Z, Hao X, Yan M, Yao M, Ge C, Gu J and
Li J: Cancer stem/progenitor cells are highly enriched in
CD133+CD44+ population in hepatocellular
carcinoma. Int J Cancer. 126:2067–2078. 2010.PubMed/NCBI
|
|
15
|
Espandiari P, Robertson LW, Srinivasan C
and Glauert HP: Comparison of different initiation protocols in the
resistant hepatocyte model. Toxicology. 206:373–381. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yamashita T, Honda M, Nakamoto Y, et al:
Discrete nature of EpCAM+ and CD90+ cancer
stem cells in human hepatocellular carcinoma. Hepatology.
57:1484–1497. 2013.PubMed/NCBI
|
|
17
|
Malanchi I, Peinado H, Kassen D, et al:
Cutaneous cancer stem cell maintenance is dependent on β-catenin
signalling. Nature. 452:650–653. 2008.
|
|
18
|
Zhao C, Chen A, Jamieson CH, et al:
Hedgehog signalling is essential for maintenance of cancer stem
cells in myeloid leukaemia. Nature. 458:776–779. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Viale A, De Franco F, Orleth A, et al:
Cell-cycle restriction limits DNA damage and maintains self-renewal
of leukaemia stem cells. Nature. 457:51–56. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cui H, Hu B, Li T, Ma J, Alam G, Gunning
WT and Ding HF: Bmi-1 is essential for the tumorigenicity of
neuroblastoma cells. Am J Pathol. 170:1370–1378. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim JH, Yoon SY, Kim CN, et al: The Bmi-1
oncoprotein is overexpressed in human colorectal cancer and
correlates with the reduced p16INK4a/p14ARF proteins. Cancer Lett.
203:217–224. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Song K, Wu J and Jiang C: Dysregulation of
signaling pathways and putative biomarkers in liver cancer stem
cells (Review). Oncol Rep. 29:3–12. 2013.PubMed/NCBI
|
|
23
|
Fan X, Matsui W, Khaki L, Stearns D, Chun
J, Li YM and Eberhart CG: Notch pathway inhibition depletes
stem-like cells and blocks engraftment in embryonal brain tumors.
Cancer Res. 66:7445–7452. 2006. View Article : Google Scholar
|
|
24
|
Verma UN, Surabhi RM, Schmaltieg A,
Becerra C and Gaynor RB: Small interfering RNAs directed against
β-catenin inhibit the in vitro and in vivo growth of
colon cancer cells. Clin Cancer Res. 9:1291–1300. 2003.
|
|
25
|
Piccirillo SG, Reynolds BA, Zanetti N, et
al: Bone morphogenetic proteins inhibit the tumorigenic potential
of human brain tumour-initiating cells. Nature. 444:761–765. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
DiDonato JA, Mercurio F and Karin M: NF-κB
and the link between inflammation and cancer. Immunol Rev.
246:379–400. 2012.
|
|
27
|
Prud’homme GJ: Cancer stem cells and novel
targets for antitumor strategies. Curr Pharm Des. 18:2838–2849.
2012.PubMed/NCBI
|
|
28
|
Ning BF, Ding J, Yin C, et al: Hepatocyte
nuclear factor 4α suppresses the development of hepatocellular
carcinoma. Cancer Res. 70:7640–7651. 2010.
|
